Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy
 For more images, please select "images" in the filters.
A comparison of methods for estimating survival probabilities in two stage phase III randomized clinical trials
PDF
Survival of children and adolescents with low-risk non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated with surgery only: an analysis of 234 patients from the Children’s Oncology Group stud...
PDF
An assessment of impact of early local progression on subsequent risk for the treatment failure in adolescent and young adult patients with non-metastatic osteosarcoma
PDF
Molecular classification, diagnosis and prognosis of pediatric rhabdomyosarcoma by oligonucleotide microarray analyses
PDF
Clinical trial availability for adolescents and young adults with cancer
PDF
An assessment of the dependence of routine assessments of the scheduling the estimation of event rates in follow‐up trials
PDF
Effects of demographic and tumor characteristics on outcomes in children with malignant peripheral nerve sheath tumors
PDF
Comparison for efficacy and toxicity in 2 vs 3 cycles of cisplatin consolidation therapy in children nasopharyngeal carcinoma
PDF
Extremity primary tumors in non-rhabdomyosarcoma soft tissue sarcoma: survival analysis
PDF
Carboplatin and vincristine chemotherapy for progressive low grade gliomas in pediatric patients with or without neurofibromatosis type 1 (NF1)
PDF
Childhood cancer survivorship: parental factors associated with survivor's follow-up care behavior and mental health
PDF
PDF
Explore risk and protective factors of undifferentiated embryonal sarcoma of the liver
PDF
Anti-neuroblastoma effects of retinoic acid, interactions with chemotherapeutic agents, and regulation of MYCN expression
PDF
Comparison of secondary and primary thyroid cancer in adolescents and young adults (AYA)
PDF
The role of adipocyte-derived free-fatty acids in acute lymphoblastic leukemia
PDF
Identifying novel combination for multidrug-resistant neuroblastoma with TP53 mutations
PDF
Phase I clinical trial designs: range and trend of expected toxicity level in standard A+B designs and an extended isotonic design treating toxicity as a quasi-continuous variable
PDF
BMI-1 expression inversely correlates with differentiation but not clinical outcome or CDKN2A expression in Ewing sarcoma family of tumors
PDF
Ph.D. Dissertation
PDF